Cohen Klingenstein’s Vertex Pharmaceuticals VRTX Stock Holding History

Cohen Klingenstein’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.98M	Hold	6,000	–	–	0.09%	99
2026 Q1	$2.68M	Hold	6,000	–	–	0.09%	102
2025 Q4	$2.72M	Hold	6,000	–	–	0.08%	98
2025 Q3	$2.35M	Hold	6,000	–	–	0.07%	106
2025 Q2	$2.67M	Hold	6,000	–	–	0.09%	97
2025 Q1	$2.91M	Hold	6,000	–	–	0.11%	90
2024 Q4	$2.42M	Hold	6,000	–	–	0.08%	104
2024 Q3	$2.79M	Hold	6,000	–	–	0.1%	108
2024 Q2	$2.81M	Hold	6,000	–	–	0.1%	103
2024 Q1	$2.51M	Hold	6,000	–	–	0.09%	110
2023 Q4	$2.44M	Hold	6,000	–	–	0.1%	111
2023 Q3	$2.09M	Hold	6,000	–	–	0.09%	114
2023 Q2	$2.11M	Hold	6,000	–	–	0.09%	117
2023 Q1	$1.89M	Hold	6,000	–	–	0.09%	119
2022 Q4	$1.73M	Hold	6,000	–	–	0.09%	130
2022 Q3	$1.74M	Hold	6,000	–	–	0.09%	119
2022 Q2	$1.69M	Hold	6,000	–	–	0.08%	127
2022 Q1	$1.57M	Hold	6,000	–	–	0.07%	136
2021 Q4	$1.32M	Hold	6,000	–	–	0.05%	152
2021 Q3	$1.09M	Hold	6,000	–	–	0.05%	170
2021 Q2	$1.21M	Hold	6,000	–	–	0.05%	170
2021 Q1	$1.29M	Hold	6,000	–	–	0.06%	157
2020 Q4	$1.42M	Hold	6,000	–	–	0.07%	146
2020 Q3	$1.63M	Hold	6,000	–	–	0.09%	127
2020 Q2	$1.74M	Hold	6,000	–	–	0.11%	124
2020 Q1	$1.43M	Hold	6,000	–	–	0.11%	122
2019 Q4	$1.31M	Hold	6,000	–	–	0.08%	142
2019 Q3	$1.02M	Buy	+6,000	New	+$1.06M	0.06%	155

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

MLL

Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return

Cohen Klingenstein's VRTX Position: Q2 2026 in Review

Cohen Klingenstein held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 6,000 shares worth $2.98M. The position accounts for 0.09% of the portfolio, ranked #99.

Cohen Klingenstein first reported a position in VRTX in Q3 2019 and has held it in 28 quarters since. 316 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Cohen Klingenstein held 6,000 shares of Vertex Pharmaceuticals worth $2.98M as of Q2 2026.
Cohen Klingenstein left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.09% of Cohen Klingenstein's portfolio in Q2 2026, its #99 holding.
Cohen Klingenstein first reported a position in Vertex Pharmaceuticals in Q3 2019 and has held it in 28 quarters since.
316 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Cohen Klingenstein's 13F filing for Q2 2026, filed 15 Jul 2026.